↓ Skip to main content

Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer

Overview of attention for article published in Gynecologic Oncology, June 2008

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

policy
1 policy source
patent
2 patents

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer
Published in
Gynecologic Oncology, June 2008
DOI 10.1016/j.ygyno.2008.04.028
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Japan 1 3%
Unknown 32 97%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Other 5 15%
Student > Bachelor 5 15%
Student > Master 5 15%
Researcher 5 15%
Student > Ph. D. Student 3 9%
Other 4 12%
Unknown 6 18%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 13 39%
Nursing and Health Professions 3 9%
Agricultural and Biological Sciences 3 9%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Chemistry 1 3%
Other 1 3%
Unknown 11 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 July 2022.
All research outputs
#4,920,204
of 33,276,949 outputs
Outputs from Gynecologic Oncology
#1,097
of 6,821 outputs
Outputs of similar age
#16,769
of 128,854 outputs
Outputs of similar age from Gynecologic Oncology
#6
of 44 outputs
Altmetric has tracked 33,276,949 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,821 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 128,854 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.